Concourse Financial Group Securities, Inc. Milestone Pharmaceuticals Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.8 - $2.41 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$1.43 - $2.36 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$1.29 - $1.65 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$1.29 - $1.83 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$1.4 - $2.2 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$1.67 - $3.39 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$2.68 - $3.69 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$2.68 - $3.69 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$2.85 - $4.4 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$3.14 - $4.2 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$3.53 - $9.5 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$5.86 - $9.43 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$5.13 - $7.37 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$4.1 - $8.24 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	SELL	$5.47 - $7.13 $1,340 - $1,746	-245 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.4 - $21.9 $3,773 - $5,365	245 New	245 $4,000
Q3 2019 Nov 13, 2019	BUY	$15.67 - $25.96 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.37 - $27.15 $0 - $0	0 New	0 $0

Others Institutions Holding MIST

# of Institutions

Shares Held

16.8M

Call Options Held

341K

Put Options Held

70.3K

Black Rock Inc. New York, NY

4.97M
Shares

$8.65 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

2.51M
Shares

$4.36 Million
0.03% of portfolio
Propel Bio Management, LLC Los Angeles, CA

1.45M
Shares

$2.53 Million
1.35% of portfolio
Alta Fundamental Advisers LLC New York, NY

1.43M
Shares

$2.48 Million
0.56% of portfolio
Bml Capital Management, LLC Zionsville, IN

1.14M
Shares

$1.98 Million
0.74% of portfolio

View Full List

About Milestone Pharmaceuticals Inc.

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $52.2M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

More about MIST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account